Simultaneous multifunctional transcriptome engineering by CRISPR RNA scaffold
Nucleic Acids Research · 11.08.2023 · 51 (14) · e77-e77
DOI: 10.1093/nar/gkad547 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 03.07.2023. Verfasst von Zukai Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA. Hauptthemen laut MEDLINE: RNA, CRISPR-Cas Systems. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHGRI NIH HHS, National Human Genome Research Institute.
Abstract (Originalsprache)
RNA processing and metabolism are subjected to precise regulation in the cell to ensure integrity and functions of RNA. Though targeted RNA engineering has become feasible with the discovery and engineering of the CRISPR-Cas13 system, simultaneous modulation of different RNA processing steps remains unavailable. In addition, off-target events resulting from effectors fused with dCas13 limit its application. Here we developed a novel platform, Combinatorial RNA Engineering via Scaffold Tagged gRNA (CREST), which can simultaneously execute multiple RNA modulation functions on different RNA targets. In CREST, RNA scaffolds are appended to the 3’ end of Cas13 gRNA and their cognate RNA binding proteins are fused with enzymatic domains for manipulation. Taking RNA alternative splicing, A-to-G and C-to-U base editing as examples, we developed bifunctional and tri-functional CREST systems for simultaneously RNA manipulation. Furthermore, by fusing two split fragments of the deaminase domain of ADAR2 to dCas13 and/or PUFc respectively, we reconstituted its enzyme activity at target sites. This split design can reduce nearly 99% of off-target events otherwise induced by a full-length effector. The flexibility of the CREST framework will enrich the transcriptome engineering toolbox for the study of RNA biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.
- Department of Genetics and Genome Sciences, University of Connecticut Health Center, Farmington, CT 06030, USA.
- The Jackson Laboratory Cancer Center, Bar Harbor, ME 04609, USA.
- Institute for Systems Genomics, University of Connecticut Health Center, Farmington, CT 06030, USA.
- School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ 85281, USA.
ORCID-Profile: Albert Wu Cheng
Förderung
- NCI NIH HHS
- NHGRI NIH HHS
- National Human Genome Research Institute
- laboratory startup funds
- NIH
Zitieren
APA
Liu, Z., Jillette, N., Robson, P., & Cheng, A. W. (2023). Simultaneous multifunctional transcriptome engineering by CRISPR RNA scaffold. Nucleic Acids Research, 51(14), e77-e77. https://doi.org/10.1093/nar/gkad547
Vancouver
Liu Z, Jillette N, Robson P, Cheng AW. Simultaneous multifunctional transcriptome engineering by CRISPR RNA scaffold. Nucleic Acids Research. 2023;51(14):e77-e77. doi:10.1093/nar/gkad547
BibTeX
@article{Liu2023,
author = {Liu, Zukai and Jillette, Nathaniel and Robson, Paul and Cheng, Albert Wu},
title = {Simultaneous multifunctional transcriptome engineering by CRISPR RNA scaffold},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {14},
pages = {e77--e77},
doi = {10.1093/nar/gkad547}
}
EUVIMED